How to evaluate Stock solution stability according to EMA guideline [Bioanalytics]

posted by chandru – India, 2018-05-27 23:26 (2183 d 16:59 ago) – Posting: # 18819
Views: 2,818

Hi Ohlbe,

Is it ok to evaluate working solution stability according to FDA guidance May 2018 at LQC and HQC level.

As they have spoken about stock solution stability which has to be done at LQC and HQC level. Does it apply for working solution stability?


Thanks,
Chandru

Complete thread:

UA Flag
Activity
 Admin contact
23,029 posts in 4,834 threads, 1,644 registered users;
30 visitors (0 registered, 30 guests [including 6 identified bots]).
Forum time: 16:26 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5